Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Rabies exposure and prophylaxis

Infectious diseases, microbiology and sexual health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Possible rabies exposure or symptomatic rabies

Any plausible bite, scratch, mucosal saliva exposure or direct bat contact requires same-day assessment because post-exposure treatment is highly effective before symptoms but rabies is almost invariably fatal after neurological disease begins.

Action: Wash and irrigate immediately, verify exposure and previous vaccine details, contact the UKHSA Rabies and Immunoglobulin Service for risk allocation and product supply, give indicated vaccine and HRIG without avoidable delay, and urgently isolate and notify any symptomatic suspected case.

Synopsis

Assess mammal and bat exposures immediately, perform effective wound care, obtain UKHSA risk allocation, and deliver correctly timed vaccine and immunoglobulin before symptoms develop.

  • Rabies virus and related lyssaviruses are transmitted when infectious saliva from a mammal reaches broken skin or mucosa; dogs cause most human rabies globally.
  • Immediately wash every wound with soap and running water for about 15 minutes, irrigate thoroughly and apply a virucidal antiseptic when available.
  • Record country, exact location and date, animal species and behaviour, provoked or unprovoked contact, ownership, vaccination, availability for observation or testing, wound site and depth.
  • Contact the UKHSA Rabies and Immunoglobulin Service for individual green, amber or red risk allocation; do not substitute a remembered country list for the current algorithm.
  • A non-immunosuppressed person who is not fully immunised and has an amber or red exposure generally receives four intramuscular vaccine doses on days 0, 3, 7 and 21.
  • A fully immunised, non-immunosuppressed person with an amber or red exposure generally receives two vaccine doses on day 0 and day 3 to 7, without routine HRIG.
  • An immunosuppressed exposed person receives HRIG when indicated and five vaccine doses on days 0, 3, 7, 14 and 30, with specialist assessment of response.
  • When UKHSA authorises human rabies immunoglobulin, use 20 IU/kg and infiltrate as much as anatomically feasible into and around all wounds; never exceed the calculated dose.
  • Pregnancy and breastfeeding are not contraindications to post-exposure vaccination or immunoglobulin because untreated rabies risk is catastrophic.
  • Rabies is clinician-notifiable in England; suspected symptomatic disease requires immediate health-protection, infection, neurology and critical-care coordination.

Key red flags

A transdermal bite or scratch, saliva on broken skin or mucosa, or direct bat exposure in a rabies-risk setting needs urgent formal assessment.

Headache, fever, paraesthesia or pain at the bite followed by agitation, hydrophobia, aerophobia, dysphagia or autonomic instability suggests furious rabies.

Ascending flaccid weakness after an animal exposure may be paralytic rabies and can be mistaken for Guillain–Barré syndrome.

A bite to the face, head, neck, hand or genitals, multiple deep wounds or exposure in a child increases concern because innervation and inoculum may shorten risk pathways.

Immunosuppression changes the post-exposure schedule and requires HRIG plus five vaccine doses even when previous vaccination history appears reassuring.

Do not postpone prophylaxis while trying to source the animal or await laboratory testing unless UKHSA explicitly advises that observation or testing resolves the risk.

Relevant bite or scratch

Teeth or claws breach skin in a risk country or through direct bat contact, allowing saliva-contaminated inoculation.

Mucosal or broken-skin exposure

Investigation priorities

01
Structured exposure historyFirst step

Provide the information UKHSA needs to allocate green, amber or red risk.

Management branches

FIRST AIDClean before anything else

A possible rabies exposure has just occurred or presents with an untreated wound.

  1. Wash and flush wounds immediately with soap and running water for about 15 minutes, then use a virucidal antiseptic such as povidone-iodine when available.
  2. Remove visible foreign material and assess tendon, nerve, vascular and infection damage; update tetanus and manage ordinary bacterial bite risk separately.
  3. Avoid primary tight closure where possible; if closure is necessary, infiltrate authorised HRIG first and use minimal loose suturing after surgical advice.
  4. Do not apply irritants, cautery or a tight tourniquet, and do not allow excellent wound care to delay contact with UKHSA.

Key medicines

Rabies vaccine for non-fully immunised exposureGive one full intramuscular dose on days 0, 3, 7 and 21 for a non-immunosuppressed person with UKHSA-classified amber or red risk who is not fully immunised.Use the product-specific full dose regardless of body weight, inject into the deltoid rather than buttock, document batch and timing, and do not withhold because of pregnancy or breastfeeding.
Rabies vaccine after full immunisationGive one full intramuscular dose on day 0 and a second on day 3 to 7 for a fully immunised, non-immunosuppressed person with amber or red risk.Confirm that the previous regimen meets the current fully immunised definition; uncertain documents, intradermal schedules, immunosuppression or major delay require UKHSA interpretation.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Rabies: risk assessment, post-exposure treatment, management
  • Rabies post-exposure treatment: management guidelines
  • Rabies: summary of risk assessment and treatment (text version)
  • Interim recommendations for human rabies immunoglobulin (HRIG) use
  • Human rabies: public health management of a suspected case

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Saliva reaches eye, mouth, nose or an existing abrasion even when no bite mark is visible.
Prodromal rabies

Fever, headache, malaise and distinctive pain, itching or paraesthesia at a healed exposure site precede neurological deterioration.

Furious rabies

Agitation, fluctuating confusion, phobic inspiratory spasms triggered by water or air, hypersalivation and autonomic instability dominate.

Paralytic rabies

Flaccid weakness begins near the exposure and ascends, eventually causing sphincter, bulbar and respiratory failure without classic hydrophobia.

Advanced disease

Coma, seizures, arrhythmia, haemodynamic instability, respiratory failure and multiorgan complications precede death in most symptomatic cases.